Market Cap | ₹12,254Cr |
ROE | 12.16% |
P/E Ratio(TTM) | 64.32 |
EPS(TTM) | 23.27 |
P/B Ratio | 9.34 |
Dividend Yield | 0.10% |
Industry P/E | 40.33 |
Book Value | 160.21 |
Debt to Equity | 0.01 |
Face Value | 5 |
Parent Organisation | Acutaas Chemicals |
Managing Director | Mr. Nareshkumar Patel |
NSE Symbol | ACUTAAS |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Divi's Laboratories | NA (0.00%) | 75.45 | ||
Neuland Laboratories | NA (0.00%) | 118.92 | ||
Jubilant Pharmova | NA (0.00%) | 38.23 | ||
Aarti Drugs | NA (0.00%) | 24.97 |